PIP
AMGN icon

Peachtree Investment Partners’s Amgen AMGN Stock Holding History

Peachtree Investment Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$227K Buy
628
+36
+6% +$12.3K 0.07% 99
2026
Q1 		$208K Sell
592
-40
-6% -$14.3K 0.08% 92
2025
Q4 		$207K Buy
+632
New +$200K 0.07% 91
2024
Q4 		– Sell
-642
Closed -$207K – 117
2024
Q3 		$207K Buy
+642
New +$210K 0.08% 83

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Peachtree Investment Partners's AMGN Position: Q2 2026 in Review

Peachtree Investment Partners increased its Amgen (AMGN) stake by 6.1% in Q2 2026, buying an estimated $12.3K and bringing the position to 628 shares worth $227K. The position accounts for 0.07% of the portfolio, ranked #99.

Peachtree Investment Partners first reported a position in AMGN in Q3 2024 and has held it in 4 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Peachtree Investment Partners held 628 shares of Amgen worth $227K as of Q2 2026.
  • Peachtree Investment Partners bought 36 Amgen shares in Q2 2026, an estimated $12.3K.
  • Amgen made up 0.07% of Peachtree Investment Partners's portfolio in Q2 2026, its #99 holding.
  • Peachtree Investment Partners first reported a position in Amgen in Q3 2024 and has held it in 4 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Peachtree Investment Partners's 13F filing for Q2 2026, filed 6 Aug 2026.